Zurueck zur Suche

Reporte zur Charge U034522

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

11Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
OK 7 VA 1 AR 1 FL 1 CA 1

VAERS 2447887

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U034522

schwer
Staat
OK
Alter
0,2
Geschlecht
M
Eingang
16.09.2022
Impfdatum
08.09.2022
Beginn
08.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Body temperature increased Seizure like phenomena

Symptomtext

Patient reported to the ED with reports of seizure like activity 5-6 times with the onset at 7:00 pm. Patient temp upon arrival is 102.5 F. Patient was treated with 70mg Tylenol and temperature resolved. No further seizure like activity. Patient was not postictal in the ED and had no witnessed seizure activity. Advised to Follow up with PCP. Patient was seen by PCP on 09/09/2022. Provider advised it is presumably an adverse effect from the DTaP vaccine. Patient appears well on exam, no further seizure-like activity.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure like phenomena
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Sacral Dimple with skin tag, Congenital Hydronephrosis
Andere Medikamente
None known
Allergien
No Known Allergies
Vorherige Impfungen
-

VAERS 2622166

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U034522

mild
Staat
VA
Alter
3,0
Geschlecht
F
Eingang
27.04.2023
Impfdatum
26.04.2023
Beginn
26.04.2023
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Headache Incorrect dose administered Pain Pain in extremity Product preparation error

Symptomtext

Client received undiluted does of Pfizer. Client was given 0.2ml (20mcg) of undiluted of 6month -4years old bivalent Pfizer. Client was notified 30mins after vaccination. Client had no symptoms at this time. Client was called again the next morning (17 hours later) and client complains of, left sore arm, mild headache and body aches. Client's mother declined to be seen at HD today by MD. Mother didn't think it was necessary at this time. Educated to stay hydrated and resources given for Health Department. Will follow up again this afternoon.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
Flu like symptoms recently but not during date of vaccination.
Vorgeschichte
None
Andere Medikamente
N/A
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2444970

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U034522

mild
Staat
AR
Alter
1,0
Geschlecht
M
Eingang
14.09.2022
Impfdatum
02.09.2022
Beginn
13.09.2022
Tage bis Beginn
11,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash Rash erythematous Rash macular Respiratory tract congestion

Symptomtext

Patient developed a diffuse, erythematous, confluent macular rash on the face, chest, abdomen, arms, and legs 12 days after vaccine administration. Rash was not pruritic. No pustules or vesicles. Associated mild congestion. No cough, vomiting, diarrhea, fever. No treatment at home. Recommended topical emollients for comfort and the use of benadryl if itching developed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2507821

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U034522

gering
Staat
OK
Alter
1,0
Geschlecht
U
Eingang
15.11.2022
Impfdatum
21.10.2022
Beginn
21.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product use issue

Symptomtext

No additional AE; a dose of improperly stored vaccine was administered to a patient on 21 OCT 2022; This spontaneous report was received from a vaccine coordinator and refers to a 12-month-old patient of unknown gender. The patient's pertinent medical history, current conditions, drug reactions or allergies and concomitant medications were not reported. On 21-OCT-2022, the patient was vaccinated with a dose of improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, lot #U034522, expiration date: 22-JUN-2024, administered for prophylaxis (dose, strength, site, and route of administration were not provided) (product use issue). The temperature excursion included 33.6 Fahrenheit (F) for 3 hours and 46.9F for 1 hour 48 minutes. The previous temperature excursion included 34.3F for 48 minutes, 34.3F for 1 hour 42 minutes, 34.9F for 1 hour 18 minutes and 34.3F for 1 hour 18 minutes. No additional adverse events details or product quality complaints were reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2502666

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U034522

gering
Staat
OK
Alter
0,3
Geschlecht
U
Eingang
09.11.2022
Impfdatum
24.10.2022
Beginn
24.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No adverse effects were reported. No additional information was provided to further clarify these details. No additional AE.; improperly stored vaccines were administered to a patient on 24 OCT 2022.; This spontaneous report was received from a vaccine coordinator, concerning a 4-month-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, previously drug reactions or allergies, and concomitant medications were not provided. On an unknown date, there was a temperature excursion registered for haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) and rotavirus vaccine, live, oral, pentavalent (ROTATEQ), of 33.6 Fahrenheit degrees (F) for 3 hours, and 46.9 (F) for 1 hour 48 minutes. Additionally, it was reported that there were previous temperature excursions of 34.3 (F) for 0 hours 48 minutes, 34.3 (F) for 1 hour 42 minutes, 34.9 (F) for 1 hour 18 minutes, and 34.3 (F) for 1 hour 18 minutes. On 24-OCT-2022, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, lot #U034522, expiration date: 22-JUN-2024 (dose, route of administration and anatomical location were not provided); and rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, lot #W011278, expiration date: 01-NOV-2023, given orally (dose was not provided). Both vaccines were administered for prophylaxis (product storage error). No adverse effects were reported. No additional information was provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2499543

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U034522

gering
Staat
OK
Alter
-
Geschlecht
U
Eingang
04.11.2022
Impfdatum
24.10.2022
Beginn
24.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No adverse effects were reported; improperly stored dose of were administered to a patient on 24 OCT 2022; This spontaneous report was received from the vaccine coordinator, and refers to a 12-month-old patient of unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not provided. On 24-OCT-2022, the patient was vaccinated with haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, lot #U034522, expiration date: 22-JUN-2024, administered for prophylaxis (strength, and route of administration were not provided) (product storage error). No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2497450

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U034522

gering
Staat
FL
Alter
1,3
Geschlecht
M
Eingang
01.11.2022
Impfdatum
15.09.2022
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Decreased activity Drooling Eye movement disorder Somnolence Tonic clonic movements Unresponsive to stimuli

Symptomtext

the patient had his 15-month immunizations yesterday. Today he was at home being held by the grandmother when he suddenly began to have tonic-clonic contractions of the upper and lower extremities. He was unresponsive with eyes rolled up and had some drooling. The episode lasted approximately 5 minutes. EMS was called but the parents decided not to wait and instead brought the patient to the ER by car. Upon arrival the patient became sleepy and is currently awake with decreased activity level. He has not had any vomiting o diarrhea.. No fever at home. No cold runny nose or cough. There are no sick contacts at home. He has no past history of febrile seizures. There is no family history of febrile seizures.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Decreased activity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2491916

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U034522

gering
Staat
OK
Alter
0,4
Geschlecht
F
Eingang
28.10.2022
Impfdatum
13.10.2022
Beginn
13.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional AEs; administration of vaccines that experienced temperature excursion on 10/13/22; This spontaneous report was received from other health professional and refers to a 5-month-old female patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 13-OCT-2022, the patient was vaccinated with improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 2 milliliter, lot #W011278, expiration date: 01-NOV-2023, administered orally for prophylaxis (strength was not provided) and improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, 0.5 milliliter, lot #U034522, expiration date: 22-JUN-2024, administered for prophylaxis (strength and route of administration were not provided) (product storage error). No additional adverse event was reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2472226

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U034522

gering
Staat
OK
Alter
-
Geschlecht
U
Eingang
07.10.2022
Impfdatum
03.10.2022
Beginn
03.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no adverse event; improperly stored doses of PEDVAX HIB and ROTATEQ were administered to two patients; This spontaneous report was received from a vaccine coordinator referring to a patient of unknown age and gender. No information about the patient's pertinent medical history, concurrent conditions, concomitant medications, or drug reactions or allergies was provided. On 03-OCT-2022, the patient was vaccinated with improperly stored haemophilus B conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) quantity 1, lot #U034522, expiration date: 22-JUN-2024, used as directed to prevent haemophilis influenza B infection (strength, route of administration, vaccination scheme frequency, anatomical location, and dose were not reported); and rotavirus vaccine, live, oral, pentavalent (ROTATEQ), 2 milliliter oral liquid, quantity 1, lot #W011278, expiration date: 01-NOV-2023, administered orally, used as directed to prevent roatvirus infection (vaccination scheme frequency, and dose were not reported) (Product storage error). Temperature excursion as following: 34.3 Fahrenheit (F); time frame: 1 hour 18 minutes. There was no previous temperature excursion. No additional adverse event was reported (no adverse event). This is one of two reports received from the same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2472225

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U034522

gering
Staat
OK
Alter
-
Geschlecht
U
Eingang
07.10.2022
Impfdatum
04.10.2022
Beginn
04.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE's were reported; A vaccine coordinator reported that improperly stored doses of PEDVAX HIB and ROTATEQ were administered to two patients.; This spontaneous report was received from a vaccine coordinator referring to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies were not reported. On an unknown date, vaccines included haemophilus B conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (lot #U034522, expiration date: 22-JUN-2024) and rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot #W011278, expiration date: 01-NOV-2023) underwent a temperature excursion at 34.3 Fahrenheit (F) for 1 hour 18 minutes. There was no previous temperature excursion. On 04-OCT-2022, the patient was vaccinated with improperly stored doses of haemophilus B conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection (quantity: 1, lot #U034522, expiration date: 22-JUN-2024; strength, dose and route of administration were not provided) used as directed to prevent haemophilis influenza B infection; and rotavirus vaccine, live, oral, pentavalent (ROTATEQ), 2 milliliter oral liquid, quantity: 1, lot #W011278, expiration date: 01-NOV-2023, administered orally as directed to prevent rotavirus infection (Product storage error). No additional AE's and no PQC's were reported (No adverse event). This is one of two reports received from the same reporter.; Sender's Comments: US-009507513-2210USA001275:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2359839

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (OTHER) · Charge U034522

gering
Staat
CA
Alter
0,2
Geschlecht
M
Eingang
06.07.2022
Impfdatum
21.06.2022
Beginn
25.06.2022
Tage bis Beginn
4,0
Dosis
1
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Explorative laparotomy Ileocolectomy Intussusception Pathology test

Symptomtext

This patient developed intussusception irreducible by air enema requiring ex-lap with ileocecetomy 5 days after Rotavirus vaccine administration. Pathology was negative for a lead point.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Explorative laparotomy
Hospital-Tage
4,0
Labordaten
Exploratory laparotomy 6/26
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
n/a
Allergien
none
Vorherige Impfungen
-